JJP Biologics to execute in-human clinical trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
JJP Biologics has received a positive conclusion on the Clinical Trial Application assessment for a Phase I Study of a potential…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.